Intellia Therapeutics, Inc. logo NTLA - Intellia Therapeutics, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY 0
BUY 29
HOLD 7
SELL 3
STRONG
SELL 0
| PRICE TARGET: $23.40 DETAILS
HIGH: $49.00
LOW: $9.00
MEDIAN: $20.50
CONSENSUS: $23.40
UPSIDE: 81.82%
AlphaVal

AlphaVal

Deterministic, archetype-aware fair value

AlphaVal Unavailable

AlphaVal: NTLA has had negative net income and negative EPS in all 5 available fiscal year(s). Quality gate: persistently unprofitable companies are excluded.